13-15, Hiyoshi 7-chome
Kohoku-ku
Yokohama 223-0061
Japan
81 4 5560 6607
https://www.koashoji-hd.com
Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 297
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Toshiyuki Shuto | President, CEO & Chairman of the Board of Directors | N/D | N/D | 1947 |
Mr. Miyoko Komatsu | Director in charge of Finance & Accounting & Director | N/D | N/D | 1964 |
Mr. Toshinori Koyama | Executive MD of Sales & Director | N/D | N/D | 1948 |
Mr. Teruyuki Tanaka | Director in charge of Business Development & Corporate Planning & Director | N/D | N/D | 1950 |
Mr. Toshihiro Hirono | Director of Production & Director | N/D | N/D | 1949 |
Ms. Ritsuko Ohtsuka | MD, Sustainability Officer & Director | N/D | N/D | 1978 |
Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells active pharmaceutical ingredients (APIs) in Japan. The company is involved in the manufacture and marketing of OTC drugs and health foods; primarily various vitamins; and manufacture and sale of generic APIs and drugs, as well as pharmaceuticals comprising injections. It also engages in contract manufacturing of pharmaceuticals; packaging of pharmaceutical products; and purchase and sale of pharmaceuticals. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.
L'ISS Governance QualityScore di Koa Shoji Holdings Co.,Ltd. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.